Rosenberg Matthew Hamilton Unity Biotechnology, Inc. Call Options Transaction History

Rosenberg Matthew Hamilton

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $13.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

Stay updated on Rosenberg Matthew Hamilton with notifications on news.